APAntonios Patrinos

Antonios Patrinos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Antonios Patrinos has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Small hospitals in battle against COVID-19: A single-center cohort study

    by Antonios Patrinos, Dimitris Komninos, Andreas Kartsonakis, Dimitris Serpanos, Niki Tsolka, Leonidas Stellas, Dimitra Dimitropoulou

    Introduction: In Greece, higher morbidity and mortality due to COVID-19 pandemic were recorded during the third pandemic wave. Only a small percentage of the population was fully vaccinated at the beginning of the third pandemic wave. Our effort was multi-level, from the emergency room...


  • Open Access

    Surgical administration of multiple glomus tumors in uncommon anatomic regions in a 17-year-old female. A rare case report

    by Theodoros Mariolis-Sapsakos, Maria Zarokosta, Nikolaos Lazaridis, Despoina Mourtzoukou, Dimitrios Vlachodimitropoulos, Antonios Patrinos, Aikaterini Foutsitzi, George Paraskevas

    Glomus tumor (GT) constitutes a rare, benign, soft-tissue tumor emerging from neuro-myo-arterial glomus bodies. Due to its rarity, and absence of typical symptoms, GT is usually misdiagnosed, with a potential risk of rupture and infection, or even malignant transformation. The present manuscript reports a rare case of a 17-year-old young woman with multiple GTs in her lower back, breach and left thigh that was surgically treated. The manuscript aims to highlight the importance of prompt diagnosis and surgical treatment of this peculiar tumor in young patients and raise surgeons’ awareness.


  • Open Access

    Case Report: An immunocompromised, vaccine breakthrough COVID-19 patient with pneumonia

    by Antonios Patrinos, Dimitris Komninos, Katerina Dimouli, Andreas Kartsonakis, Dimitris Serpanos, Georgios Kalogeropoulos, Dimitra Dimitropoulou

    Background: The novel SARS-CoV-2 pandemic has inflicted a major blow on public health worldwide accounting for millions of deaths and subsequent socio-economic consequences. The main challenge for scientists and researchers has been to restrain transmission of the virus and prevent severe respiratory disease. Novel promising vaccines aim to fulfil these expectations, although new variants of the coronavirus have emerged. The present manuscript aims to add to the knowledge, through a case of an immunodeficient patient, who developed remarkably favorable recovery from SARS-CoV-2 pneumonia after having been fully vaccinated against the novel coronavirus. Case presentation: An 82-year-old Caucasian male with a history of metastatic pancreatic cancer was admitted with signs and symptoms of pneumonia. Workup revealed a positive SARS-CoV-2 real time – polymerase chain reaction (RT-PCR) and further investigation identified a B.1.1.7 variant. The imaging essays showed extensive lung disease. Interestingly, the patient had already received the second dose of the BNT162b2 (Pfizer) vaccine against the new coronavirus 16 days prior. After having been treated with appropriate antiviral and antibiotical agents the patient showed significantly favorable recovery and no need for high oxygen flows and no complications presented. The patient was discharged after six days of hospitalization in good condition, with no need for supplementary oxygen at home. Conclusions: Despite breakthrough cases, vaccination against COVID-19 is crucial for restraining the novel coronavirus. Further studies should be carried out in order to determine the optimal strategies for large-scale vaccination while minimizing the risk of further and faster evolution of the virus.


  • Open Access

    The clavipectoral fascia as the unique anatomical criteria for distinguishing breast parenchymal lesions from axillary lymph node metastasis

    by Antonios Patrinos, Maria Zarokosta, John Tsiaoussis, George Noussios, Theodoros Piperos, Menelaos Zoulamoglou, Ioannis Flessas, Theodoros Mariolis–Sapsakos

    In the original version of this report the affiliation of Dr. John Tsiaoussis was incorrectly listed. This has now been corrected and the author apologises for the error.

  • Open Access

    The clavipectoral fascia as the unique anatomical criteria for distinguishing breast parenchymal lesions from axillary lymph node metastasis

    by Antonios Patrinos, Maria Zarokosta, John Tsiaoussis, George Noussios, Τheodoros Piperos, Menelaos Zoulamoglou, Ioannis Flessas, Theodoros Mariolis–Sapsakos

    Diagnosing primary breast tumors of the axillary tail of Spence may be extremely challenging, since several lesions may be located in the axillary fossa. In the presented case, a 54-year-old post-menopausal Caucasian female patient presented to our institution complaining about a lump in her left axilla. The preoperative imaging modalities could not clarify whether the tumor is part of the tail of Spence or metastasis of the axillary lymph nodes. The diagnosis of primary adenocarcinoma of the axillary tail of Spence was made during a quadrantectomy of the left breast after the clavipectoral fascia, which constitutes the sole anatomical boundary between breast and axilla, was identified.